Interestingly, progression to the chronic phase of AD, which is characterized by CP and lichenification/tissue remodeling, is followed by an increased Th2-immune signature, with over-expression of pruritogenic cytokines (IL-13, TSLP) among others [73]. This evidence concerns the gene IL13 and Alzheimer disease.